ReviewCurrent clinical pharmacology2010

Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis.

Véronique Dartois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.